JPMorgan Downgrades Pacific Biosciences of California (PACB) to Underweight

JPMorgan downgraded Pacific Biosciences of California (NASDAQ: PACB) from Neutral to Underweight, maintains price target of $8.00.

For more ratings news on Pacific Biosciences of California click here and for the rating history of Pacific Biosciences of California click here.

Shares of Pacific Biosciences of California closed at $5.56 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Pacific Biosciences of California (PACB) PT Lowered to $8 at Scotiabank
• Pacific Biosciences of California (PACB) PT Lowered to $3.50 at Canaccord Genuity
• Pacific Biosciences of California (PACB) PT Lowered to $2.50 at TD Cowen